HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Citigroup raised HP Inc. HPQ price target from $31 to $33. Citigroup analyst Asiya Merchant upgraded the stock from Neutral to Buy. HP shares rose 2.2% to close at $27.62 on Friday. See how other analysts view this stock.
UBS increased the price target for Noah Holdings Limited NOAH from $16.3 to $18. UBS analyst Helen Li upgraded the stock from Neutral to Buy. Noah Holdings shares gained 1.6% to $11.57 in pre-market trading. See how other analysts view this stock.
Piper Sandler slashed Health Catalyst, Inc. HCAT price target from $12 to $11. Piper Sandler analyst Jessica Tassan upgraded Health Catalyst from Neutral to Overweight. Health Catalyst shares gained 3.1% to $6.92 in pre-market trading. See how other analysts view this stock.
Keefe, Bruyette & Woods increased the price target for AXIS Capital Holdings Limited AXS from $59 to $66. Keefe, Bruyette & Woods analyst Meyer Shields upgraded the stock from Market Perform to Outperform. AXIS Capital shares gained 0.9% to close at $53.82 on Friday. See how other analysts view this stock.
HC Wainwright & Co. cut the price target for Nouveau Monde Graphite Inc. NMG from $9 to $8. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Nouveau Monde Graphite shares gained 2.6% to $2.79 in pre-market trading. See how other analysts view this stock.
Wells Fargo cut Barings BDC, Inc. BBDC price target from $9 to $8.5. Wells Fargo analyst Finian O'Shea downgraded the stock from Overweight to Equal-Weight. Barings BDC shares fell 1.6% to $8.80 in pre-market trading. See how other analysts view this stock.
B of A Securities cut Paramount Group, Inc. PGRE price target from $5 to $4. B of A Securities analyst Camille Bonnel downgraded the stock from Neutral to Underperform. Paramount Group shares fell 3% to $4.27 in pre-market trading. See how other analysts view this stock.
Wells Fargo slashed the price target for Crescent Capital BDC, Inc. CCAP from $16.5 to $16. Wells Fargo analyst Finian O'Shea downgraded the stock from Overweight to Equal-Weight. Crescent Capital BDC shares fell 1.4% to $16.78 in pre-market trading. See how other analysts view this stock.
Barclays cut Waters Corporation WAT price target from $270 to $230. Barclays analyst Luke Sergott downgraded the stock from Equal-Weight to Underweight. Waters shares gained 1.1% to close at $255.92 on Friday. See how other analysts view this stock.
Goldman Sachs cut GoodRx Holdings, Inc. GDRX price target from $7 to $6. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. GoodRx shares fell 1.7% to $4.71 in pre-market trading. See how other analysts view this stock.